|
Status |
Public on Mar 10, 2007 |
Title |
Tumorigenic (T3TG_B) |
Sample type |
RNA |
|
|
Source name |
breast tumor
|
Organism |
Homo sapiens |
Characteristics |
tumorigenic population (ESA+ CD44+ CD24-/low Lin-)
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol extraction of total RNA was performed according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol
|
|
|
Hybridization protocol |
Following fragmentation, 15 ug of cRNA were hybridized according to the manufacturer's instructions.
|
Scan protocol |
none
|
Description |
Tumorigenic population (ESA+ CD44+ CD24-/low Lin-) of a breast tumor isolated using fluorescence activated cell sorting. Sample consists of three replicates.
|
Data processing |
To obtain an expression measure for a given probeset, the mismatch hybridization values were subtracted from the perfect match values, and the average of the middle 50% of these differences was used as the expression measure for the probe set. A quantile normalization procedure was then applied to adjust for differences in the probe intensity distribution across different chips. Specifically, we applied a monotone linear spline to each chip that mapped quantiles 0.01 up to 0.99 (in increments of 0.01) exactly to the corresponding quantiles of a standard chip. The transform log2 [200 + max(X;0)] was then applied.
|
|
|
Submission date |
Jan 26, 2007 |
Last update date |
Mar 09, 2007 |
Contact name |
Xinhao Wang |
E-mail(s) |
[email protected]
|
Phone |
650-995-8211
|
Organization name |
OncoMed Pharmaceuticals Inc
|
Street address |
800 Chesapeake
|
City |
Redwood City |
State/province |
CA |
ZIP/Postal code |
94063 |
Country |
USA |
|
|
Platform ID |
GPL97 |
Series (1) |
GSE6883 |
The prognostic role of a gene signature from tumorigenic breast-cancer cells. |
|